Metabolic Syndrome and Chronic Renal Disease

Background: The influence of metabolic syndrome (MetS) on kidneys is related to many complications. We aimed to assess the association between MetS and chronic renal disease defined by a poor estimated glomerular filtration rate (eGFR) and/or the presence of microalbuminuria/macroalbuminuria. Method...

Full description

Bibliographic Details
Main Authors: Vaia D. Raikou, Sotiris Gavriil
Format: Article
Language:English
Published: MDPI AG 2018-01-01
Series:Diseases
Subjects:
Online Access:http://www.mdpi.com/2079-9721/6/1/12
id doaj-76bcb7260e2a403bb52193e32e28fdb6
record_format Article
spelling doaj-76bcb7260e2a403bb52193e32e28fdb62020-11-24T22:32:07ZengMDPI AGDiseases2079-97212018-01-01611210.3390/diseases6010012diseases6010012Metabolic Syndrome and Chronic Renal DiseaseVaia D. Raikou0Sotiris Gavriil1Department of Nephrology, Doctors’ Hospital, 26 Kefallinias, 11257 Athens, GreeceDepartment of Weight-Surgery, Doctors’ Hospital, 11257 Athens, GreeceBackground: The influence of metabolic syndrome (MetS) on kidneys is related to many complications. We aimed to assess the association between MetS and chronic renal disease defined by a poor estimated glomerular filtration rate (eGFR) and/or the presence of microalbuminuria/macroalbuminuria. Methods: 149 patients (77 males/72 females) were enrolled in the study. Chronic renal disease was defined according to KDIGO 2012 criteria based on eGFR category and classified albuminuria. MetS was studied as a dichotomous variable (0 to 5 components) including hypertension, waist circumference, low HDL-cholesterol, high triglycerides, and high glucose. Results: The association between clustering MetS and both classified eGFR and classified albuminuria (x2 = 50.3, p = 0.001 and x2 = 26.9, p = 0.003 respectively) was found to be significant. The MetS presence showed an odds 5.3-fold (1.6–17.8) higher for low eGFR and 3.2-fold (1.2–8.8) higher for albuminuria in combination with the presence of diabetes mellitus, which also increased the risk for albuminuria by 3.5-fold (1.1–11.3). Albuminuria was significantly associated with high triglycerides, hypertension, high glucose (x2 = 11.8, p = 0.003, x2 = 11.4, p = 0.003 and x2 = 9.1, p = 0.01 respectively), and it was mildly associated with a low HDL-C (x2 = 5.7, p = 0.06). A significant association between classified eGFR and both high triglycerides and hypertension (x2 = 9.7, p = 0.04 and x2 = 16.1, p = 0.003 respectively) was found. Conclusion: The clustering of MetS was significantly associated with chronic renal disease defined by both classified eGFR and albuminuria. The definition of impaired renal function by classified albuminuria was associated with more MetS components rather than the evaluation of eGFR category. MetS may contribute to the manifestation of albuminuria in patients with diabetes mellitus.http://www.mdpi.com/2079-9721/6/1/12metabolic syndromehypertensionrenal diseasealbuminuriatriglycerideseGFR
collection DOAJ
language English
format Article
sources DOAJ
author Vaia D. Raikou
Sotiris Gavriil
spellingShingle Vaia D. Raikou
Sotiris Gavriil
Metabolic Syndrome and Chronic Renal Disease
Diseases
metabolic syndrome
hypertension
renal disease
albuminuria
triglycerides
eGFR
author_facet Vaia D. Raikou
Sotiris Gavriil
author_sort Vaia D. Raikou
title Metabolic Syndrome and Chronic Renal Disease
title_short Metabolic Syndrome and Chronic Renal Disease
title_full Metabolic Syndrome and Chronic Renal Disease
title_fullStr Metabolic Syndrome and Chronic Renal Disease
title_full_unstemmed Metabolic Syndrome and Chronic Renal Disease
title_sort metabolic syndrome and chronic renal disease
publisher MDPI AG
series Diseases
issn 2079-9721
publishDate 2018-01-01
description Background: The influence of metabolic syndrome (MetS) on kidneys is related to many complications. We aimed to assess the association between MetS and chronic renal disease defined by a poor estimated glomerular filtration rate (eGFR) and/or the presence of microalbuminuria/macroalbuminuria. Methods: 149 patients (77 males/72 females) were enrolled in the study. Chronic renal disease was defined according to KDIGO 2012 criteria based on eGFR category and classified albuminuria. MetS was studied as a dichotomous variable (0 to 5 components) including hypertension, waist circumference, low HDL-cholesterol, high triglycerides, and high glucose. Results: The association between clustering MetS and both classified eGFR and classified albuminuria (x2 = 50.3, p = 0.001 and x2 = 26.9, p = 0.003 respectively) was found to be significant. The MetS presence showed an odds 5.3-fold (1.6–17.8) higher for low eGFR and 3.2-fold (1.2–8.8) higher for albuminuria in combination with the presence of diabetes mellitus, which also increased the risk for albuminuria by 3.5-fold (1.1–11.3). Albuminuria was significantly associated with high triglycerides, hypertension, high glucose (x2 = 11.8, p = 0.003, x2 = 11.4, p = 0.003 and x2 = 9.1, p = 0.01 respectively), and it was mildly associated with a low HDL-C (x2 = 5.7, p = 0.06). A significant association between classified eGFR and both high triglycerides and hypertension (x2 = 9.7, p = 0.04 and x2 = 16.1, p = 0.003 respectively) was found. Conclusion: The clustering of MetS was significantly associated with chronic renal disease defined by both classified eGFR and albuminuria. The definition of impaired renal function by classified albuminuria was associated with more MetS components rather than the evaluation of eGFR category. MetS may contribute to the manifestation of albuminuria in patients with diabetes mellitus.
topic metabolic syndrome
hypertension
renal disease
albuminuria
triglycerides
eGFR
url http://www.mdpi.com/2079-9721/6/1/12
work_keys_str_mv AT vaiadraikou metabolicsyndromeandchronicrenaldisease
AT sotirisgavriil metabolicsyndromeandchronicrenaldisease
_version_ 1725734893870120960